TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

E3611-A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced Melanoma.

Ahmad A Tarhini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.